Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Jacobs

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Vaccines|January 8, 2025
Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older AdultsBart Jacobs, Isabel Leroux-Roels, Jacques Bruhwyler, et al.
The Journal of Infectious Diseases|October 24, 2024
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 StudyIsabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Endovascular transatrial stenting of pulmonary vein stenosis after lung transplantationMichaela Orlitová, Marc Gewillig, Jan Van Slambrouck, et al.
Oncotarget|December 30, 2016
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cellsAlbert Bosch-Vilaró, Bart Jacobs, Valentina Pomella, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 24, 2013
DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotypeVeerle De Vriendt, Wendy De Roock, Antonio Fabio Di Narzo, et al.
Oncotarget|October 11, 2014
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signalingLayka Abbasi Asbagh, Iria Vazquez, Loredana Vecchione, et al.
The Journal of Cardiovascular Surgery|February 22, 2020
Endovascular treatment of atherosclerotic lesions in the superficial femoral artery and proximal popliteal artery using the sinus-SuperFlex-635 stent: twelve-month results from the HERO RegistryJeroen M Hendriks, Marc Dubois, Patrick Lauwers, et al.
Scientific Reports|October 7, 2025
Concentrations of ciprofloxacin in food defined as safe alter the gut microbiome and ciprofloxacin susceptibility in humans: an interventional clinical studySheeba Manoharan-Basil, Zina Gestels, Said Abdellati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2014
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapyZenia Saridaki, Joanne B Weidhaas, Heinz-Josef Lenz, et al.
Frontiers in Immunology|October 24, 2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineIsabel Leroux-Roels, Cathy Maes, Jasper Joye, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Vaccines|January 8, 2025
Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older AdultsBart Jacobs, Isabel Leroux-Roels, Jacques Bruhwyler, et al.
The Journal of Infectious Diseases|October 24, 2024
Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 StudyIsabel Leroux-Roels, Azhar Alhatemi, Magalie Caubet, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Endovascular transatrial stenting of pulmonary vein stenosis after lung transplantationMichaela Orlitová, Marc Gewillig, Jan Van Slambrouck, et al.
Oncotarget|December 30, 2016
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cellsAlbert Bosch-Vilaró, Bart Jacobs, Valentina Pomella, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 24, 2013
DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotypeVeerle De Vriendt, Wendy De Roock, Antonio Fabio Di Narzo, et al.
Oncotarget|October 11, 2014
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signalingLayka Abbasi Asbagh, Iria Vazquez, Loredana Vecchione, et al.
The Journal of Cardiovascular Surgery|February 22, 2020
Endovascular treatment of atherosclerotic lesions in the superficial femoral artery and proximal popliteal artery using the sinus-SuperFlex-635 stent: twelve-month results from the HERO RegistryJeroen M Hendriks, Marc Dubois, Patrick Lauwers, et al.
Scientific Reports|October 7, 2025
Concentrations of ciprofloxacin in food defined as safe alter the gut microbiome and ciprofloxacin susceptibility in humans: an interventional clinical studySheeba Manoharan-Basil, Zina Gestels, Said Abdellati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2014
A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapyZenia Saridaki, Joanne B Weidhaas, Heinz-Josef Lenz, et al.
Frontiers in Immunology|October 24, 2022
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccineIsabel Leroux-Roels, Cathy Maes, Jasper Joye, et al.
Pageof 8